TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MAIA

MAIA Biotechnology Inc.

Healthcare · Biotechnology

1.40$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns MAIA Biotechnology Inc. (MAIA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.1% of the shares are freely tradable; institutional investors hold 21.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 21.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 14.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 61Mio.

Largest Shareholders

No ownership data is available for this stock yet.

Insider holdings

Insider holdings MAIA
Person Role Shares Value As of Type
Vitoc Vlad Chief Executive Officer 1,049,121 1,468,769 $ Sep 14, 2026 direct
Guerrero Ramiro Director 773,296 1,082,614 $ Sep 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Vitoc Vlad Chief Executive Officer Buy 73,000 1.37 100,010
Sep 10, 2026 Guerrero Ramiro Director Buy 37,595 1.32 49,516
Aug 28, 2026 Guerrero Ramiro Director Buy 46,620 1.35 62,937
Aug 27, 2026 Guerrero Ramiro Director Buy 78,239 1.39 108,752
Aug 26, 2026 Guerrero Ramiro Director Buy 8,931 1.39 12,414
Aug 24, 2026 Guerrero Ramiro Director Buy 1,794 1.33 2,386
Aug 20, 2026 Guerrero Ramiro Director Buy 11,899 1.37 16,302

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?